Calcitriol in the treatment of prostate cancer1

Tomasz M. Beer, Anne Myrthue

    Research output: Contribution to journalReview articlepeer-review

    43 Scopus citations


    Calcitriol, the principal active metabolite of vitamin D and a naturally occurring hormone, showed significant antineoplastic activity in pre-clinical models of prostate cancer and many other tumor types. These antineoplastic effects were observed at calcitriol concentrations substantially above the physiological range. While a number of mechanisms of action have been postulated, the induction of apoptosis and inhibition of proliferation have been most extensively reported. These pre-clinical findings motivated several investigators to pursue a series of clinical trials to examine the potential of targeting the vitamin D receptor for cancer treatment using calcitriol. Initial studies tested daily dosing of calcitriol and showed that substantial dose escalation was not feasible due to hypercalciuria and/or hypercalcemia. In contrast, weekly dosing of calcitriol allowed substantial dose escalation without dose-limiting toxicities. Notably, however, the commercially available formulation of calcitriol exhibited non-linear pharmacokinetics at the highest doses tested. While substantially higher concentrations were achieved, the maximum tolerated dose was not established due to this pharmacological limitation. Intermittently-dosed calcitriol was then combined with several antineoplastic agents, including steroids, bisphosphonates and chemotherapeutic agents. The activity seen in a phase II study of weekly calcitriol plus docetaxel was particularly encouraging and led to the development of DN-101, a proprietary formulation designed for cancer treatment. DN-101 in combination with docetaxel is being evaluated in a placebo-controlled randomized clinical trial that has completed accrual.

    Original languageEnglish (US)
    Pages (from-to)2647-2651
    Number of pages5
    JournalAnticancer research
    Issue number4 A
    StatePublished - Jul 1 2006


    • Calcitriol
    • Prostate cancer
    • Review
    • Vitamin D

    ASJC Scopus subject areas

    • Oncology
    • Cancer Research


    Dive into the research topics of 'Calcitriol in the treatment of prostate cancer1'. Together they form a unique fingerprint.

    Cite this